Sirolimus Ointment for Facial Angiofibromas in Individuals with Tuberous Sclerosis Complex

Background. Facial angiofibromas affect most patients with tuberous sclerosis complex. They tend to progress, can cause recurrent bleeding and facial disfigurement, and have significant psychological effects. We reviewed the effectiveness and safety of topical sirolimus ointment 0.1%. We also assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, S., Lux, A., Khan, A., O'Callaghan, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705889/
https://www.ncbi.nlm.nih.gov/pubmed/29270462
http://dx.doi.org/10.1155/2017/8404378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705889/
https://www.ncbi.nlm.nih.gov/pubmed/29270462
http://dx.doi.org/10.1155/2017/8404378

Ejemplares similares